Results 1 to 10 of about 522,558 (297)

Antenatal Corticosteroids and Respiratory Distresses Outcome in Preterm Neonates [PDF]

Iranian Journal of Neonatology, 2021
Background: The value of antenatal corticosteroid regimen in lessening respiratory distress risk in preterm neonates has been well known, and accordingly, antenatal corticosteroid therapy was recommended for any pregnant woman likely to deliver between ...
Fatma Mohamed, Badr El Din Mesbah, Abdelmoneim Khashana   +2 more
doaj   +1 more source

Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review

Frontiers in Pharmacology, 2022
Due to the fact that coronavirus disease 2019 (COVID-19) is still prevalent, and current reports show that some parts of the world have seen increase in incidence, it is relevant that health professionals and scientists know about recent or novel trends,
Seth Kwabena Amponsah, Benjamin Tagoe, Ismaila Adams, Kwasi Agyei Bugyei   +3 more
doaj   +1 more source

Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin

Frontiers in Immunology, 2022
Pathogenesis of lung injury in COVID-19 is not completely understood, leaving gaps in understanding how current treatments modulate the course of COVID-19.
Jorge Adrian Masso-Silva, Jorge Adrian Masso-Silva, George Sakoulas, George Sakoulas, Jarod Olay, Jarod Olay, Victoria Groysberg, Matthew Geriak, Victor Nizet, Victor Nizet, Laura E. Crotty Alexander, Laura E. Crotty Alexander, Angela Meier   +12 more
doaj   +1 more source

Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis

Intensive Care Medicine, 2021
Corticosteroids are now recommended for patients with severe COVID-19 including those with COVID-related ARDS. This has generated renewed interest regarding whether corticosteroids should be used in non-COVID ARDS as well. The objective of this study was
D. Chaudhuri, K. Sasaki, Aram Karkar, Sameer Sharif, K. Lewis, M. Mammen, P. Alexander, Z. Ye, L. E. C. Lozano, M. W. Munch, A. Perner, B. Du, L. Mbuagbaw, W. Alhazzani, S. Pastores, J. Marshall, F. Lamontagne, D. Annane, G. Meduri, B. Rochwerg   +19 more
semanticscholar   +1 more source

Systemic corticosteroids for the treatment of COVID-19.

Cochrane Database of Systematic Reviews, 2021
BACKGROUND Systemic corticosteroids are used to treat people with COVID-19 because they counter hyper-inflammation. Existing evidence syntheses suggest a slight benefit on mortality.
C. Wagner, M. Griesel, A. Mikołajewska, Anika Mueller, M. Nothacker, K. Kley, Maria-Inti Metzendorf, Anna-Lena Fischer, Marco Kopp, M. Stegemann, N. Skoetz, F. Fichtner   +11 more
semanticscholar   +1 more source

Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma

Blood, 2021
Corticosteroids are used to treat the acute complications of chimeric antigen receptor (CAR) T-cell therapy. Strati et al examine the impact of corticosteroids on patient outcomes following CAR T-cell therapy for large B-cell lymphoma.
P. Strati, Saira S. Ahmed, Fateeha Furqan, L. Fayad, H. Lee, S. Iyer, R. Nair, L. Nastoupil, S. Parmar, M. Rodriguez, F. Samaniego, R. Steiner, Michael L. Wang, C. Pinnix, S. Horowitz, Lei Feng, R. Sun, Catherine M. Claussen, Misha C. Hawkins, Nicole A. Johnson, Prachee Singh, H. Mistry, S. Johncy, S. Adkins, P. Kebriaei, E. Shpall, Michael R. Green, C. Flowers, J. Westin, S. Neelapu   +29 more
semanticscholar   +1 more source

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.

Journal of the American Medical Association (JAMA), 2020
Importance Effective therapies for patients with coronavirus disease 2019 (COVID-19) are needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced mortality in hospitalized patients with COVID-19 who required respiratory ...
J. Sterne, S. Murthy, Janet Diaz, Arthur S Slutsky, J. Villar, D. Angus, D. Annane, L. Azevedo, O. Berwanger, A. Cavalcanti, P. Dequin, B. Du, J. Emberson, D. Fisher, B. Giraudeau, A. Gordon, A. Granholm, Cameron Green, R. Haynes, Nicholas Heming, J. Higgins, P. Horby, P. Jüni, M. Landray, A. Le Gouge, M. Leclerc, W. Lim, F. Machado, C. McArthur, F. Meziani, M. Møller, A. Perner, M. W. Petersen, J. Savović, B. Tomazini, V. Veiga, S. Webb, J. Marshall   +37 more
semanticscholar   +1 more source

Atypical Stevens–Johnson syndrome caused by pembrolizumab in the treatment of metastatic melanoma – Are corticosteroids a safe treatment option?

Journal of Dermatology and Dermatologic Surgery, 2020
Pembrolizumab is a humanized monoclonal antibody that targets programmed cell death receptor-1. Stevens–Johnson syndrome (SJS) secondary to pembrolizumab has rarely been described in the treatment of malignant melanoma (MM). A 62-year-old woman developed
Cathal O'Connor, Emmet Jordan, Michael O'Connell   +2 more
doaj   +1 more source

Respiratory virus type to guide predictive enrichment approaches in the management of the first episode of bronchiolitis: A systematic review

Frontiers in Immunology, 2022
It has become clear that severe bronchiolitis is a heterogeneous disease; even so, current bronchiolitis management guidelines rely on the one-size-fits-all approach regarding achieving both short-term and chronic outcomes.
Dominika Ambrożej, Dominika Ambrożej, Heidi Makrinioti, Abigail Whitehouse, Nikolas Papadopoulos, Nikolas Papadopoulos, Marek Ruszczyński, Aleksander Adamiec, Aleksander Adamiec, Jose A. Castro-Rodriguez, Khalid Alansari, Khalid Alansari, Khalid Alansari, Tuomas Jartti, Tuomas Jartti, Tuomas Jartti, Wojciech Feleszko   +16 more
doaj   +1 more source

Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19

medRxiv, 2020
Background: There is no proven antiviral or immunomodulatory therapy for COVID-19. The disease progression associated with the pro-inflammatory host response prompted us to examine the role of early corticosteroid therapy in patients with moderate to ...
R. Fadel, A. Morrison, A. Vahia, Zachary R. Smith, Z. Chaudhry, P. Bhargava, Joseph B. Miller, Rachel M. Kenney, G. Alangaden, M. Ramesh   +9 more
semanticscholar   +1 more source